Brief: Nyxoah: FDA Approves MRI Compatibility For Genio System
Feb 9 (Reuters) - Nyxoah SA NYXH.BR :
* NYXOAH RECEIVES FDA APPROVAL FOR FULL-BODY 1.5T AND 3T MRI
COMPATIBILITY FOR THE GENIO® SYSTEM TO TREAT OBSTRUCTIVE SLEEP
APNEA (OSA)
Source text for Eikon: ID:nGNE8KZ8Ss
Further company coverage: NYXH.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Nyxoah SA
See all newsBelgium's Nyxoah Q3 revenue rises on US commercialization
Brief: Nyxoah SA Q3 Gross Profit EUR 5.785 Million
Brief: Nyxoah SA Submits Pma Supplement To FDA To Expand Genio Indication To Complete Concentric Collapse Patients
Brief: Nyxoah Says Co Appoints Liam Kelly As Chief Executive Officer Effective October 1
Brief: Cvrx Appoints John Landry As Chief Financial Officer